.png){kind=logo}
Results with less work
Automated insulin delivery and smart dosing systems designed to give more peace of mind and reduce diabetes burden.
Freedom to customize therapy
MiniMed FlexTM system
Automated insulin pump therapy
Freedom at mealtimes
The smallest pump with Meal DetectionTM technology† that helps to keep glucose levels in range — even if they’re not a perfect carb counter or sometimes forget to bolus.‡§◊
Freedom to wear their way§
Small, sleek, and designed to stay tucked away all day while they deliver boluses and check their numbers from a phone. Available on iOS and Android.
Freedom from daily injections
Designed for once-a-week◊ changes and charging.
- Multiple infusion set options, including a 7-day infusion set — that means 96% fewer injections than traditional insulin shots.¶
- Easy-to-insert sensor options, including the 15-day Instinct sensor, made by Abbott, or the Simplera SyncTM sensor.
MiniMed GoTM system
Smart insulin pen therapy
Remembers
Automatically records doses in the app so there's less to keep track of. Comprehensive data for informed treatment decisions.
Reminds
Alerts when more insulin is needed to keep levels in range — without unecessary notifications. Actionable alerts across devices help users stay on track.
Recommends
Calculates the right dose for meals and corrections, factoring in glucose, active insulin, and missed doses to help prevent lows. Data-driven dosing guidance.
Refer a patient
When you refer a patient to us, our team ensures they're fully supported every step of the way — handling insurance, device set-up, training, and therapy check-ins.
The MiniMed difference
For over 40 years, we've been a trusted partner in the diabetes community. Our innovation and support help people around the world do less work and have more freedom.
Advanced insulin delivery
Our automated insulin delivery and smart dosing systems are designed to give more peace of mind and reduce diabetes burden.
Getting started, simplified
We make it easy to try new technology with an intuitive, guided experience that helps people start with confidence and ease.
Building the hands-free future
We're leading the way in building what's next, with a goal of providing technology that can handle diabetes management on its own.
Footnotes
† Refers to SmartGuardTM feature. Individual results may vary.
‡ Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
§ Do not wear or place your pump more than 14 in (35.5 cm) above your infusion site. Doing so can cause an over-delivery of insulin, which may result in hypoglycemia
¶ Assumes 4 injections per day for 30 days and one infusion set change every seven days.
◊ Assumes one infusion set every seven days. More insertions may be required if the Extended infusion set requires replacement before specified wear time.
# Proper pairing, connectivity, and settings required. Talk to your healthcare professional before establishing and changing your settings. Ensure that all doses taken with InPen are logged in the app, that all doses taken with a device other than InPen are logged manually in the app, and that glucose and meal information entered into the dose calculator are current and accurate. Not doing so can result in incorrect dosing, hypoglycemia or hyperglycemia, and serious injury.
References
1. Why CGM alone is not enough: low actionability of CGM alerts without considering impact of active insulin. M.B. Smith, G. Im, J. MacLeod, R.A. Vigersky; Abstract #758. 59th annual EASD meeting 5 Oct 2023. (actionability of CGM alerts)
Important safety information: MiniMed Go system
The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see https://link.minimed.com/Risks.